224 related articles for article (PubMed ID: 36197274)
1. Radiomics approach based on biphasic CT images well differentiate "early stage" of adrenal metastases from lipid-poor adenomas: A STARD compliant article.
Cao L; Xu W
Medicine (Baltimore); 2022 Sep; 101(38):e30856. PubMed ID: 36197274
[TBL] [Abstract][Full Text] [Related]
2. Two nomograms based on radiomics models using triphasic CT for differentiation of adrenal lipid-poor benign lesions and metastases in a cancer population: an exploratory study.
Wang G; Kang B; Cui J; Deng Y; Zhao Y; Ji C; Wang X
Eur Radiol; 2023 Mar; 33(3):1873-1883. PubMed ID: 36264313
[TBL] [Abstract][Full Text] [Related]
3. Machine learning for differentiation of lipid-poor adrenal adenoma and subclinical pheochromocytoma based on multiphase CT imaging radiomics.
Xiao DX; Zhong JP; Peng JD; Fan CG; Wang XC; Wen XL; Liao WW; Wang J; Yin XF
BMC Med Imaging; 2023 Oct; 23(1):159. PubMed ID: 37845636
[TBL] [Abstract][Full Text] [Related]
4. Small hyperattenuating adrenal nodules in patients with lung cancer: Differentiation of metastases from adenomas on biphasic contrast-enhanced computed tomography.
Cao L; Zhang L; Xu W
Front Oncol; 2023; 13():1091102. PubMed ID: 36865810
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of adrenal adenomas from adrenal metastases in single-phased staging dual-energy CT and radiomics.
Winkelmann MT; Gassenmaier S; Walter SS; Artzner C; Lades F; Faby S; Nikolaou K; Bongers MN
Diagn Interv Radiol; 2022 May; 28(3):208-216. PubMed ID: 35748202
[TBL] [Abstract][Full Text] [Related]
6. CT-based radiomics nomogram for differentiation of adrenal hyperplasia from lipid-poor adenoma: an exploratory study.
Yuan H; Kang B; Sun K; Qin S; Ji C; Wang X
BMC Med Imaging; 2023 Jan; 23(1):4. PubMed ID: 36611159
[TBL] [Abstract][Full Text] [Related]
7. Dual-energy CT in the differentiation between adrenal adenomas and metastases: Usefulness of material density maps and monochromatic images.
Cano Alonso R; Álvarez Vázquez A; Andreu Vázquez C; Thuissard Vasallo IJ; Fernández Alfonso A; Recio Rodríguez M; Martínez de Vega V
Radiologia (Engl Ed); 2023; 65(5):402-413. PubMed ID: 37758331
[TBL] [Abstract][Full Text] [Related]
8. Radiomics in the characterization of lipid-poor adrenal adenomas at unenhanced CT: time to look beyond usual density metrics.
Feliciani G; Serra F; Menghi E; Ferroni F; Sarnelli A; Feo C; Zatelli MC; Ambrosio MR; Giganti M; Carnevale A
Eur Radiol; 2024 Jan; 34(1):422-432. PubMed ID: 37566266
[TBL] [Abstract][Full Text] [Related]
9. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
10. Radiomics Signatures of Computed Tomography Imaging for Predicting Risk Categorization and Clinical Stage of Thymomas.
Wang X; Sun W; Liang H; Mao X; Lu Z
Biomed Res Int; 2019; 2019():3616852. PubMed ID: 31275968
[TBL] [Abstract][Full Text] [Related]
11. CT-based radiomics research for discriminating the risk stratification of pheochromocytoma using different machine learning models: a multi-center study.
Zhao J; Zhan Y; Zhou Y; Yang Z; Xiong X; Ye Y; Yao B; Xu S; Peng Y; Xiao X; Zeng X; Zuo M; Dai X; Gong L
Abdom Radiol (NY); 2024 May; 49(5):1569-1583. PubMed ID: 38587628
[TBL] [Abstract][Full Text] [Related]
12. Differentiating the pathological subtypes of primary lung cancer for patients with brain metastases based on radiomics features from brain CT images.
Zhang J; Jin J; Ai Y; Zhu K; Xiao C; Xie C; Jin X
Eur Radiol; 2021 Feb; 31(2):1022-1028. PubMed ID: 32822055
[TBL] [Abstract][Full Text] [Related]
13. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
[TBL] [Abstract][Full Text] [Related]
14. CT-based radiomics analysis of different machine learning models for differentiating benign and malignant parotid tumors.
Zheng Y; Zhou D; Liu H; Wen M
Eur Radiol; 2022 Oct; 32(10):6953-6964. PubMed ID: 35484339
[TBL] [Abstract][Full Text] [Related]
15. Radiomics Analysis of Multiphasic Computed Tomography Images for Distinguishing High-Risk Thymic Epithelial Tumors From Low-Risk Thymic Epithelial Tumors.
Liufu Y; Wen Y; Wu W; Su R; Liu S; Li J; Pan X; Chen K; Guan Y
J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):220-228. PubMed ID: 36877755
[TBL] [Abstract][Full Text] [Related]
16. Multiphasic CT-Based Radiomics Analysis for the Differentiation of Benign and Malignant Parotid Tumors.
Yu Q; Wang A; Gu J; Li Q; Ning Y; Peng J; Lv F; Zhang X
Front Oncol; 2022; 12():913898. PubMed ID: 35847942
[TBL] [Abstract][Full Text] [Related]
17. A Preliminary Study for Distinguish Hormone-Secreting Functional Adrenocortical Adenoma Subtypes Using Multiparametric CT Radiomics-Based Machine Learning Model and Nomogram.
Zheng Y; Liu X; Zhong Y; Lv F; Yang H
Front Oncol; 2020; 10():570502. PubMed ID: 33117700
[No Abstract] [Full Text] [Related]
18. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis.
Xue B; Wu S; Zhang M; Hong J; Liu B; Xu N; Zeng Q; Tang K; Zheng X
Abdom Radiol (NY); 2021 Aug; 46(8):3835-3844. PubMed ID: 33728532
[TBL] [Abstract][Full Text] [Related]
19. Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.
Li SQ; Su LL; Xu TF; Ren LY; Chen DB; Qin WY; Yan XZ; Fan JX; Chen HS; Liao WJ
World J Gastroenterol; 2023 Jul; 29(26):4186-4199. PubMed ID: 37475840
[TBL] [Abstract][Full Text] [Related]
20. Can radiomic feature analysis differentiate adrenal metastases from lipid-poor adenomas on single-phase contrast-enhanced CT abdomen?
O'Shea A; Kilcoyne A; McDermott E; O'Grady M; McDermott S
Clin Radiol; 2022 Oct; 77(10):e711-e718. PubMed ID: 35948490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
